Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nephrology (Carlton) ; 20(12): 916-21, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26058859

RESUMO

AIM: It has been reported that the innate immune system plays a pivotal role in the pathogenesis of immunoglobulin A nephropathy (IgAN). To explore non-invasive monitoring of disease activity in children with IgAN, we examined whether expressions of mRNA for innate immunity-associated functional molecules: CC ligand chemokine 5 (CCL5), fractalkine/CX3CL1, interferon-γ-induced protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1), retinoic acid-inducible gene-I (RIG-I), and toll-like receptor 3 (TLR3) in urinary sediment from patients with IgAN correlate with histologic parameters. METHODS: Twenty consecutive children with IgAN and four children with thin basement membrane disease (serving as a non-inflammatory control) were enrolled in this pilot study. Urinary mRNA expressions of target genes were examined real-time quantitative polymerase chain reaction. RESULTS: The expressions of CCL5, fractalkine and RIG-I were significantly increased in IgAN (all P < 0.05). Although no significant correlation was observed between mRNA expressions of these three molecules and clinical parameters, such as levels of urinary protein excretion, degrees of occult blood in urine and serum albumin, the expression of fractalkine was significantly correlated with the histological activity index (P = 0.022) and the chronicity index (P = 0.005). Furthermore, intense glomerular immune activity of fractalkine was observed in biopsy specimens in patients with moderately to severe proliferative IgAN. CONCLUSION: Regional expression of fractalkine may be involved in the pathogenesis of childhood IgAN. Although our present findings remain preliminary, measurement of mRNA expression of fractalkine in urinary sediment could be used as a non-invasive method for predicting histologic severity in IgAN in children. Further studies of this issue are needed.


Assuntos
Quimiocina CX3CL1/genética , Glomerulonefrite por IGA/genética , Imunidade Inata/genética , RNA Mensageiro/genética , Adolescente , Biópsia , Estudos de Casos e Controles , Quimiocina CCL2/genética , Quimiocina CCL2/urina , Quimiocina CCL5/genética , Quimiocina CCL5/urina , Quimiocina CX3CL1/urina , Quimiocina CXCL10/genética , Quimiocina CXCL10/urina , Criança , Proteína DEAD-box 58 , RNA Helicases DEAD-box/genética , RNA Helicases DEAD-box/urina , Feminino , Regulação da Expressão Gênica , Marcadores Genéticos , Predisposição Genética para Doença , Glomerulonefrite por IGA/diagnóstico , Glomerulonefrite por IGA/imunologia , Glomerulonefrite por IGA/urina , Humanos , Masculino , Fenótipo , Projetos Piloto , RNA Mensageiro/urina , Reação em Cadeia da Polimerase em Tempo Real , Receptores Imunológicos , Índice de Gravidade de Doença , Receptor 3 Toll-Like/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA